vimarsana.com

Guangdong Technology Financial Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

China Digest: EurekaBio, Vilory Advanced Materials snap funds

Yuexiu Industrial Fund leads EurekaBio’s extended Series B round, while Mixed Ownership Reform Fund leads Vilory’s latest funding rounds.

Guangzhou yuexiu capital holdings groupJiangsu vilory advanced materials technologyYuexiu industrial fundGuangdong technology financial groupXuzhou mining groupOwnership reform fundMixed ownership reform fundIndustrial fundEureka biotechnologyGuangzhou yuexiu capital holdingsFortune capitalTasly capitalEight roads venturesEight roadsXuzhou based vilory

Deals in brief: Purpose Venture Capital backs Bioworks, Grab injects SGD 145 1 million into GXS Bank, former Twitter CEO raises funding for AI startup, and more

Bringing you the latest news briefs on fundraising activities in the Asia Pacific.

South koreaHong kongMashonaland eastSouth koreanLinda yaccarinoLi ka shingElon muskDavid bellParag agrawalGuangdong technology financial groupSk networksYagi coSprout solutionsSusan dell foundationZuni technology groupOptimus foundation

Canton Biologics and 55 more Greater China deals worth over $356m

Founded in 2016, the Guangzhou-headquartered firm serves as a CDMO in the large molecule drug substance market.

Cantonbio deutschland gmbCanton biologicsGlycotope gmbChina state development investment corporationGuangdong technology financial groupState developmentInvestment corporationTaipu life science investmentChnin financialBio deutschland gmbhBerlin headquartered glycotope gmbh

Canton Biologics Completes Over 300 Million Yuan Series C Financing, Led by SDIC Venture Capital

On September 13th, Canton Biologics Co., Ltd. announced that it had recently completed a Series C financing round exceeding 300 million yuan. This round of financing was led by SDIC Venture Capital, with participation from Guangdong Technology

Xiao shenCanton biologicsCanton biologics co ltdGuangdong technology financial groupTaipu life science investmentCanton biologic

Canton Biologics Completes Over 300 Million Yuan Series C Financing, Led by SDIC Venture Capital

/PRNewswire/ On September 13th, Canton Biologics Co., Ltd. announced that it had recently completed a Series C financing round exceeding 300 million yuan..

Xiao shenCanton biologicsGuangdong technology financial groupCanton biologics co ltdTaipu life science investmentCanton biologicCanton biologics co

vimarsana © 2020. All Rights Reserved.